Kari L Olson

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi request reprint Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization
    Kari L Olson
    Departments of Pharmacy, Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado Region, Aurora, CO 80211, USA
    Arch Intern Med 165:49-54. 2005
  2. ncbi request reprint Outcomes of patients discharged from pharmacy-managed cardiovascular disease management
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Am J Manag Care 15:497-503. 2009
  3. pmc Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attack
    Kari L Olson
    Clinical Pharmacy Specialist in the Pharmacy Department for Kaiser Permanente Colorado and Clinical Associate Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora E mail
    Perm J 17:28-34. 2013
  4. doi request reprint Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, CO 80011, USA
    J Thromb Thrombolysis 29:316-21. 2010
  5. doi request reprint Publication rates of abstracts presented by pharmacy residents at the Western States Conference
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, 80011, USA
    Am J Health Syst Pharm 69:59-62. 2012
  6. doi request reprint A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program
    David J Magid
    Kaiser Permanente Colorado, 10065 E Harvard Ave, Denver, CO 80231, USA
    Circ Cardiovasc Qual Outcomes 6:157-63. 2013
  7. ncbi request reprint Factors associated with recurrent coronary events among patients with cardiovascular disease
    Karen J McConnell
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 29:906-13. 2009
  8. ncbi request reprint Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization
    Brian G Sandhoff
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado KPCO, Aurora, Colorado 80011, USA
    Am J Health Syst Pharm 64:77-84. 2007
  9. ncbi request reprint Statin adherence and mortality in patients enrolled in a secondary prevention program
    Brandy D McGinnis
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Am J Manag Care 15:689-95. 2009
  10. doi request reprint Reduced health care expenditures after enrollment in a collaborative cardiac care service
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 30:1127-35. 2010

Detail Information

Publications29

  1. ncbi request reprint Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization
    Kari L Olson
    Departments of Pharmacy, Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado Region, Aurora, CO 80211, USA
    Arch Intern Med 165:49-54. 2005
    ..The aim of this study is to examine the impact of a clinical pharmacy cardiac risk service (CPCRS) on lipid screening, control, and treatment outcomes...
  2. ncbi request reprint Outcomes of patients discharged from pharmacy-managed cardiovascular disease management
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Am J Manag Care 15:497-503. 2009
    ..To evaluate whether patients with coronary artery disease (CAD) discharged from the Clinical Pharmacy Cardiac Risk Service (CPCRS) would maintain their lipid goals with use of an electronic laboratory reminder system...
  3. pmc Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attack
    Kari L Olson
    Clinical Pharmacy Specialist in the Pharmacy Department for Kaiser Permanente Colorado and Clinical Associate Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora E mail
    Perm J 17:28-34. 2013
    ..This study evaluated goal attainment for patients with a history of non-cardioembolic ischemic stroke (NCIS) or transient ischemic attack (TIA)...
  4. doi request reprint Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, CO 80011, USA
    J Thromb Thrombolysis 29:316-21. 2010
    ..0; 95% CI 1.1-3.8). Post-stent treatment with warfarin, ASA, and clopidogrel was associated with a substantially greater likelihood of major hemorrhage than treatment with ASA and clopidogrel alone...
  5. doi request reprint Publication rates of abstracts presented by pharmacy residents at the Western States Conference
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, 80011, USA
    Am J Health Syst Pharm 69:59-62. 2012
    ..Investigators report the results of a study to determine the proportion of residency projects presented as abstracts at a regional residency conference that were subsequently published as full-length articles...
  6. doi request reprint A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program
    David J Magid
    Kaiser Permanente Colorado, 10065 E Harvard Ave, Denver, CO 80231, USA
    Circ Cardiovasc Qual Outcomes 6:157-63. 2013
    ..To determine whether a pharmacist-led, Heart360-enabled, home blood pressure monitoring (HBPM) intervention improves blood pressure (BP) control compared with usual care (UC)...
  7. ncbi request reprint Factors associated with recurrent coronary events among patients with cardiovascular disease
    Karen J McConnell
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 29:906-13. 2009
    ..To determine which factors are associated with recurrent coronary events...
  8. ncbi request reprint Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization
    Brian G Sandhoff
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado KPCO, Aurora, Colorado 80011, USA
    Am J Health Syst Pharm 64:77-84. 2007
    ..A clinical pharmacy service for managing the treatment of coronary artery disease in a health maintenance organization is described...
  9. ncbi request reprint Statin adherence and mortality in patients enrolled in a secondary prevention program
    Brandy D McGinnis
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Am J Manag Care 15:689-95. 2009
    ..To determine statin adherence rates in patients enrolled in a cardiovascular secondary disease prevention program and to evaluate the impact of adherence on subsequent clinical events...
  10. doi request reprint Reduced health care expenditures after enrollment in a collaborative cardiac care service
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 30:1127-35. 2010
    ..To assess the impact of a collaborative cardiovascular risk reduction service (Collaborative Cardiac Care Service [CCCS]) on total health care expenditures after an incident acute coronary event...
  11. ncbi request reprint Positive predictive values of ICD-9 codes to identify patients with stroke or TIA
    Kari L Olson
    16601 E Centretech Parkway, Aurora, CO 80011 E mail
    Am J Manag Care 20:e27-34. 2014
    ..54 for identifying confirmed history of stroke or transient ischemic attack (cerebral event) among patients within a managed care organization...
  12. ncbi request reprint Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study
    Amy B Kauffman
    Kaiser Permanente Colorado, Aurora, Colorado, USA
    Clin Drug Investig 28:501-7. 2008
    ....
  13. ncbi request reprint Assessment of patient satisfaction with telephone and mail interventions provided by a clinical pharmacy cardiac risk reduction service
    Susan L Holsclaw
    Kaiser Foundation Health Plan of Colorado, 16601 East Centretech Parkway, Aurora, CO 80011, USA
    J Manag Care Pharm 11:403-9. 2005
    ..CPCRS provides much of its care via telephone. The purpose of this study was to determine the level of satisfaction among patients in this unique service...
  14. doi request reprint Attainment of low-density lipoprotein cholesterol goals in coronary artery disease
    Amy B Kauffman
    Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, CO 80011, USA
    J Clin Lipidol 4:173-80. 2010
    ..This study evaluated the extent to which this recommendation can be attained by the use of currently available lipid-lowering therapies...
  15. ncbi request reprint Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization
    Evguenia C Charles
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado, Denver, Colorado, USA
    Am J Med 118:618-24. 2005
    ....
  16. ncbi request reprint Factors related to adherence to statin therapy
    Brandy McGinnis
    Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Ann Pharmacother 41:1805-11. 2007
    ..Retrospective database analyses have revealed that 50% of patients receiving statins discontinue therapy after one year of treatment. Typically, these data do not focus on patient-specific reasons for discontinuation...
  17. ncbi request reprint The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides
    Lisa J Schwellenbach
    Kaiser Permanente Colorado, Clinical Pharmacy Cardiac Risk Service, Aurora, CO 80011, USA
    J Am Coll Nutr 25:480-5. 2006
    ..The American Heart Association recommends 1000 mg of omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), daily for cardioprotection and higher doses for triglyceride-lowering in patients with CAD...
  18. ncbi request reprint A multimodal blood pressure control intervention in 3 healthcare systems
    David J Magid
    Institute for Health Research, Kaiser Permanente Colorado, Denver, USA
    Am J Manag Care 17:e96-103. 2011
    ....
  19. ncbi request reprint Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease
    John A Merenich
    Department of Endocrinology, Colorado Permanente Medical Group, Denver, Colorado, USA
    Pharmacotherapy 27:1370-8. 2007
    ..To determine the effect of early and sustained enrollment in a comprehensive cardiac care (CCC) program on all-cause mortality in patients with coronary artery disease (CAD)...
  20. pmc Out-of-plan pharmacy use by members of a managed care organization
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA
    Perm J 16:15-21. 2012
    ..Little is known about the use of these programs. The purpose of this study was to assess the rate and characteristics of prescriptions written in a managed care organization (MCO) to an out-of-plan pharmacy (OOPP)...
  21. ncbi request reprint Clinical and economic outcomes of conversion of simvastatin to lovastatin in a group-model health maintenance organization
    Sarah J Billups
    Kaiser Permanente Central Support Services, 16601 East Centretech Pkwy, Aurora, CO 80011, USA
    J Manag Care Pharm 11:681-6. 2005
    ....
  22. doi request reprint Interventions aimed at improving performance on medication adherence metrics
    Brandy McGinnis
    Kaiser Permanante Colorado, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, 16601 E Centretech Parkway, Aurora, CO, 80011, USA
    Int J Clin Pharm 36:20-5. 2014
    ..In the United States, national organizations such as the National Committee for Quality Assurance and the Centers for Medicare and Medicaid Services include medication adherence as a metric of health care system performance Aim of the..
  23. doi request reprint An assessment of cholesterol goal attainment in patients with chronic kidney disease
    Sheila L Stadler
    Pharmacy Department, Kaiser Permanente Colorado, 16601 East Centretech Parkway, Aurora, CO 80011, USA
    J Clin Lipidol 4:298-304. 2010
    ..The National Kidney Foundation developed clinical practice guidelines (Kidney Disease Outcomes Quality Initiative) for targeting low-density lipoprotein cholesterol (LDL-C) goals...
  24. doi request reprint Self-reported inhaler use in patients with chronic obstructive pulmonary disease
    Kory VanderSchaaf
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA
    Respir Med 104:99-106. 2010
    ..Higher education level, home oxygen use and prescriptions for ipratropium were predictors for inhaler variance. The impact of inhaler variance on morbidity of COPD should be evaluated...
  25. ncbi request reprint Monitoring of patients given second-generation antipsychotic agents
    Kari L Olson
    Psychiatr Serv 57:1045-6. 2006
  26. doi request reprint Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease
    P Michael Ho
    Cardiology Section, Denver VA Medical Center, Denver, CO, USA
    Am Heart J 155:772-9. 2008
    ..Little is known about the effect of nonadherence among patients with coronary artery disease (CAD) on a broad spectrum of outcomes including cardiovascular mortality, cardiovascular hospitalizations, and revascularization procedures...
  27. ncbi request reprint Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus)
    Ross T Tsuyuki
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am J Med 116:130-3. 2004
  28. doi request reprint Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease
    P Michael Ho
    Cardiology Section, Denver Veterans Affairs Medical Center, 1055 Clermont St, Denver, CO 80220, USA
    Arch Intern Med 168:271-6. 2008
    ..Despite the importance of blood pressure (BP) control in secondary prevention, a significant proportion of patients with coronary disease have uncontrolled BP...
  29. ncbi request reprint Patients' achievement of cholesterol targets: a cross-sectional evaluation
    Kari L Olson
    Epidemiology Coordinating and Research Centre, Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2C8
    Am J Prev Med 25:339-42. 2003
    ..This study was conducted to determine the proportion of patients achieving recommended target lipid levels in a relatively unselected group of community-dwelling patients who were prescribed HMG-CoA reductase inhibitors (statins)...